Clinical effect of allylestrenol on benign prostatic hypertrophy

Allylestrenol at the daily dose of 50 mg was administered to 45 patients with benign prostatic hypertrophy. The treatment was performed for more than 12 weeks in 40 patients, and improvements, marked and moderate, were observed in 22 patients (55%) in the overall judgement. As side effects of this d...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 3 vom: 01. März, Seite 477-85
1. Verfasser: Tajima, A (VerfasserIn)
Weitere Verfasser: Aso, Y, Ushiyama, T, Hata, M, Kambayashi, T, Ohmi, Y, Masuda, H, Nakahara, M, Kitagawa, M, Suzuki, A
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Estrenes Allylestrenol I47VB5DZ8O
Beschreibung
Zusammenfassung:Allylestrenol at the daily dose of 50 mg was administered to 45 patients with benign prostatic hypertrophy. The treatment was performed for more than 12 weeks in 40 patients, and improvements, marked and moderate, were observed in 22 patients (55%) in the overall judgement. As side effects of this drug, decrease of potency was observed in 3 cases, decrease of libido in 1 case, pigmentation on breasts in 2 cases, palpitation in 2 cases, short breath in 1 case, and gastrointestinal symptoms in 1 case. However, these side effects were not serious. Our trial suggests that the treatment of benign prostatic hypertrophy with allylestrenol can be useful in urological clinics
Beschreibung:Date Completed 11.08.1986
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE
ISSN:0018-1994